348 related articles for article (PubMed ID: 16735996)
1. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice.
Konopatskaya O; Churchill AJ; Harper SJ; Bates DO; Gardiner TA
Mol Vis; 2006 May; 12():626-32. PubMed ID: 16735996
[TBL] [Abstract][Full Text] [Related]
2. [Alternative splicing of vascular endothelial growth factor A and ocular neovascularization].
Fan SJ; He SZ
Zhonghua Yan Ke Za Zhi; 2011 Apr; 47(4):373-7. PubMed ID: 21612688
[TBL] [Abstract][Full Text] [Related]
3. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
4. VEGF-A165b is cytoprotective and antiangiogenic in the retina.
Magnussen AL; Rennel ES; Hua J; Bevan HS; Beazley Long N; Lehrling C; Gammons M; Floege J; Harper SJ; Agostini HT; Bates DO; Churchill AJ
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4273-81. PubMed ID: 20237249
[TBL] [Abstract][Full Text] [Related]
5. Heparanase and vascular endothelial growth factor expression is increased in hypoxia-induced retinal neovascularization.
Hu J; Song X; He YQ; Freeman C; Parish CR; Yuan L; Yu H; Tang S
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6810-7. PubMed ID: 22956610
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neovascularization and expression shift of pro-/anti-angiogenic vascular endothelial growth factor isoforms after intravitreal bevacizumab injection in oxygen-induced-retinopathy mouse model.
Shi X; Zhao M; Xie WK; Liang JH; Miao YF; DU W; Li XX
Chin Med J (Engl); 2013 Jan; 126(2):345-52. PubMed ID: 23324288
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
8. Expression of pro- and anti-angiogenic isoforms of VEGF in the mouse model of oxygen-induced retinopathy.
Zhao M; Shi X; Liang J; Miao Y; Xie W; Zhang Y; Li X
Exp Eye Res; 2011 Dec; 93(6):921-6. PubMed ID: 22067127
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human VEGF165b inhibits experimental choroidal neovascularization.
Hua J; Spee C; Kase S; Rennel ES; Magnussen AL; Qiu Y; Varey A; Dhayade S; Churchill AJ; Harper SJ; Bates DO; Hinton DR
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4282-8. PubMed ID: 20237252
[TBL] [Abstract][Full Text] [Related]
10. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor.
Perrin RM; Konopatskaya O; Qiu Y; Harper S; Bates DO; Churchill AJ
Diabetologia; 2005 Nov; 48(11):2422-7. PubMed ID: 16193288
[TBL] [Abstract][Full Text] [Related]
12. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
Aiello LP; Pierce EA; Foley ED; Takagi H; Chen H; Riddle L; Ferrara N; King GL; Smith LE
Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10457-61. PubMed ID: 7479819
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of bactericidal/permeability-increasing protein (BPI) analogues on retinal neovascularization and retinal pericyte growth.
Rauniyar RK; Suzuma K; King AL; Aiello LP; King GL
Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):503-9. PubMed ID: 11818397
[TBL] [Abstract][Full Text] [Related]
14. Müller cell-derived VEGF is a significant contributor to retinal neovascularization.
Bai Y; Ma JX; Guo J; Wang J; Zhu M; Chen Y; Le YZ
J Pathol; 2009 Dec; 219(4):446-54. PubMed ID: 19768732
[TBL] [Abstract][Full Text] [Related]
15. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effect of luteolin on retinal neovascularization via blockade of reactive oxygen species production.
Park SW; Cho CS; Jun HO; Ryu NH; Kim JH; Yu YS; Kim JS; Kim JH
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7718-26. PubMed ID: 23099493
[TBL] [Abstract][Full Text] [Related]
17. Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.
Vinores SA; Xiao WH; Aslam S; Shen J; Oshima Y; Nambu H; Liu H; Carmeliet P; Campochiaro PA
J Cell Physiol; 2006 Mar; 206(3):749-58. PubMed ID: 16245301
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy.
Al-Shabrawey M; Bartoli M; El-Remessy AB; Platt DH; Matragoon S; Behzadian MA; Caldwell RW; Caldwell RB
Am J Pathol; 2005 Aug; 167(2):599-607. PubMed ID: 16049343
[TBL] [Abstract][Full Text] [Related]
19. The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice.
Rennel E; Waine E; Guan H; Schüler Y; Leenders W; Woolard J; Sugiono M; Gillatt D; Kleinerman E; Bates D; Harper S
Br J Cancer; 2008 Apr; 98(7):1250-7. PubMed ID: 18349828
[TBL] [Abstract][Full Text] [Related]
20. Suppression of transient receptor potential canonical channel 4 inhibits vascular endothelial growth factor-induced retinal neovascularization.
Song HB; Jun HO; Kim JH; Fruttiger M; Kim JH
Cell Calcium; 2015 Feb; 57(2):101-8. PubMed ID: 25605522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]